11 results on '"Johnson, Tom"'
Search Results
2. ALMOST NOTHING.
- Author
-
Johnson, Tom
- Subjects
MINIMAL music ,EUROPEAN music ,MUSICAL style ,MUSIC attribution - Abstract
The author offers his insight on silent music and minimalism in Europe. He discusses minimalism which are original in style and fairly extreme in minimalism. He explores the minimalist music of Erik Satie including "Vexations," "Le Fils des Étoiles," and "Musique d'Ameublement." He also examines his favorite piece by Walter Marchetti called "Per la Sete Dell'orecchio" recorded in 1985.
- Published
- 2009
3. DIGGING DEEP.
- Author
-
Johnson, Tom
- Subjects
FIXED incomes ,FIXED-income securities ,FINANCIAL research ,FINANCIAL services industry - Abstract
The article provides information on changes in European fixed-income research. Fixed-income research is undergoing a significant retrenchment in Europe, contends Mark Howard, global head of credit research at Barclays Capital. "The European Union's Market Abuse Directive, coupled with a very tight-spread, low-volatility market environment, has encouraged some firms to realign what their researchers do, and in some cases turn their researchers into nonresearchers," he says. Jeffrey Burch, a portfolio manager at hedge fund BlueMountain Capital Management sees a similar shift in resources. "Bank of America, Citigroup and Goldman Sachs no longer have a publishing model in Europe, and Bear Stearns, Deutsche Bank and Morgan Stanley have both publishing analysts and dedicated desk analysts," he says. INSET: THE OUTSTANDING ANALYSTS OF THE YEAR.
- Published
- 2006
4. The Best of the BUY SIDE 2006.
- Author
-
Johnson, Tom
- Subjects
SECURITIES industry laws ,FINANCIAL services industry ,RESEARCH teams ,RESEARCH - Abstract
The article discusses the effect of tighter regulatory scrutiny and steep budget cutbacks on buy-side researchers in the securities industry. J.P. Morgan Asset Management boosted its London, England-based research analyst team from 18 to 20 in 2005 and it plans to add two analysts in 2006 to cover the chemicals and building materials sectors. Europe's buoyant equity market also is fueling expansion, giving institutions the wherewithal to invest in research.
- Published
- 2006
5. CHALLENGE TO KEEP MOMENTUM GOING.
- Author
-
Johnson, Tom
- Subjects
INVESTMENT advisors ,MUTUAL funds ,PORTFOLIO management (Investments) ,FINANCIAL services industry - Abstract
The article describes the condition of money managers in Europe and India. According to the author, although the money managers in both regions enjoyed record profits in 2006, they still face different challenges to keep the momentum going. Those in Europe must contend with slowing asset flows, declining performance fees and rising costs, while those in India will have to deal with the effect of investing more money in mutual funds. The author says that managers need to excite investor interest in existing funds to maintain their momentum.
- Published
- 2007
6. REASONS FOR RATIONAL EXUBERANCE.
- Author
-
Johnson, Tom
- Subjects
INSTITUTIONAL investments ,ECONOMIC development ,HEDGE funds ,INVESTORS - Abstract
The article presents an update on institutional investment. According to the International Monetary Fund, Asia, led by China and India, will enjoy economic growth in 2009. The top five firms managed to evade losses as many hedge funds suffered huge losses in 2008. New ways are being developed by European companies to keep investors informed during turbulent times.
- Published
- 2009
7. EMERGING MARKETS POISED FOR REBOUND.
- Author
-
Johnson, Tom
- Subjects
FINANCIAL crises ,EMERGING markets ,STANDARD & Poor's 500 Index ,STOCK price indexes - Abstract
This article reports on the impact of the financial crisis on the emerging markets of Europe, the Middle East and Africa in 2008. The Russian Trading System index plummeted 72.4 percent during the year--nearly double the 38.5 percent decline of the Standard & Poor's 500 index. Many analysts believe the sell off in emerging markets is mistaken, rooted in an outdated perception of developing economies as riskier than developed ones.
- Published
- 2009
8. INVESTOR ACTIVISM: TWO VIEWPOINTS.
- Author
-
Johnson, Tom
- Subjects
STOCKHOLDERS ,ACTIVISM ,INVESTMENTS ,HEDGE funds ,INVESTORS ,ASSETS (Accounting) - Abstract
The article reports that shareholder activism is reshaping the investment landscape in Europe. European hedge fund firms that employ activist tactics find that the strategy sits well with their investors. Several funds engaged in activism, most notably the Children's investment Fund Management, saw a substantial increase in their net asset values in 2006.
- Published
- 2007
9. Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI.
- Author
-
De Luca, Giuseppe, Verdoia, Monica, Cercek, Miha, Jensen, Lisette Okkels, Vavlukis, Marija, Calmac, Lucian, Johnson, Tom, Ferrer, Gerard Rourai, Ganyukov, Vladimir, Wojakowski, Wojtek, Kinnaird, Tim, van Birgelen, Clemens, Cottin, Yves, IJsselmuiden, Alexander, Tuccillo, Bernardo, Versaci, Francesco, Royaards, Kees-Jan, Berg, Jurrien Ten, Laine, Mika, and Dirksen, Maurits
- Subjects
- *
VIRAL pneumonia , *RESEARCH , *RESEARCH methodology , *COVID-19 , *MEDICAL care , *ACQUISITION of data , *RETROSPECTIVE studies , *EVALUATION research , *MEDICAL cooperation , *CARDIOVASCULAR system , *COMPARATIVE studies , *EPIDEMICS - Abstract
Background: The fear of contagion during the coronavirus disease-2019 (COVID-19) pandemic may have potentially refrained patients with ST-segment elevation myocardial infarction (STEMI) from accessing the emergency system, with subsequent impact on mortality.Objectives: The ISACS-STEMI COVID-19 registry aims to estimate the true impact of the COVID-19 pandemic on the treatment and outcome of patients with STEMI treated by primary percutaneous coronary intervention (PPCI), with identification of "at-risk" patient cohorts for failure to present or delays to treatment.Methods: This retrospective registry was performed in European high-volume PPCI centers and assessed patients with STEMI treated with PPPCI in March/April 2019 and 2020. Main outcomes are the incidences of PPCI, delayed treatment, and in-hospital mortality.Results: A total of 6,609 patients underwent PPCI in 77 centers, located in 18 countries. In 2020, during the pandemic, there was a significant reduction in PPCI as compared with 2019 (incidence rate ratio: 0.811; 95% confidence interval: 0.78 to 0.84; p < 0.0001). The heterogeneity among centers was not related to the incidence of death due to COVID-19. A significant interaction was observed for patients with arterial hypertension, who were less frequently admitted in 2020 than in 2019. Furthermore, the pandemic was associated with a significant increase in door-to-balloon and total ischemia times, which may have contributed to the higher mortality during the pandemic.Conclusions: The COVID-19 pandemic had significant impact on the treatment of patients with STEMI, with a 19% reduction in PPCI procedures, especially among patients suffering from hypertension, and a longer delay to treatment, which may have contributed to the increased mortality during the pandemic. (Primary Angioplasty for STEMI During COVID-19 Pandemic [ISACS-STEMI COVID-19] Registry; NCT04412655). [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
10. Risks and benefits of percutaneous coronary intervention in spontaneous coronary artery dissection.
- Author
-
Kotecha D, Garcia-Guimaraes M, Premawardhana D, Pellegrini D, Oliver-Williams C, Bountziouka V, Wood A, Natarajan N, Jackson R, Chan N, Ziaullah J, Rakhit RD, Hoole SP, Johnson TW, Kadziela J, Ludman P, Samani NJ, Maas AHEM, van Geuns RJ, Alfonso F, and Adlam D
- Subjects
- Coronary Angiography methods, Europe epidemiology, Female, Humans, Male, Middle Aged, Outcome and Process Assessment, Health Care, Registries statistics & numerical data, Risk Assessment, Stents, Thrombolytic Therapy methods, Thrombolytic Therapy statistics & numerical data, Vascular Diseases complications, Vascular Diseases diagnosis, Vascular Diseases epidemiology, Vascular Diseases surgery, Coronary Vessel Anomalies complications, Coronary Vessel Anomalies diagnosis, Coronary Vessel Anomalies epidemiology, Coronary Vessel Anomalies surgery, Percutaneous Coronary Intervention adverse effects, Percutaneous Coronary Intervention instrumentation, Percutaneous Coronary Intervention methods, Postoperative Complications diagnosis, Postoperative Complications epidemiology, ST Elevation Myocardial Infarction etiology, ST Elevation Myocardial Infarction therapy, Vascular Diseases congenital
- Abstract
Objective: To investigate percutaneous coronary intervention (PCI) practice in an international cohort of patients with spontaneous coronary artery dissection (SCAD). To explore factors associated with complications and study angiographic and longer term outcomes., Methods: SCAD patients (n=215, 94% female) who underwent PCI from three national cohort studies were investigated and compared with a matched cohort of conservatively managed SCAD patients (n=221)., Results: SCAD-PCI patients were high risk at presentation with only 8.8% undergoing PCI outside the context of ST-elevation myocardial infarction/cardiac arrest, thrombolysis in myocardial infarction (TIMI) 0/1 flow or proximal dissections. PCI complications occurred in 38.6% (83/215), with 13.0% (28/215) serious complications. PCI-related complications were associated with more extensive dissections (multiple vs single American Heart Association coronary segments, OR 1.9 (95% CI: 1.06-3.39),p=0.030), more proximal dissections (proximal diameter per mm, OR 2.25 (1.38-3.67), p=0.001) and dissections with no contrast penetration of the false lumen (Yip-Saw 2 versus 1, OR 2.89 (1.12-7.43), p=0.028). SCAD-PCI involved long lengths of stent (median 46mm, IQR: 29-61mm). Despite these risks, SCAD-PCI led to angiographic improvements in those with reduced TIMI flow in 84.3% (118/140). Worsening TIMI flow was only seen in 7.0% (15/215) of SCAD-PCI patients. Post-PCI major adverse cardiovascular and cerebrovascular events (MACCE) and left ventricular function outcomes were favourable., Conclusion: While a conservative approach to revascularisation is favoured, SCAD cases with higher risk presentations may require PCI. SCAD-PCI is associated with longer stent lengths and a higher risk of complications but leads to overall improvements in coronary flow and good medium-term outcomes in patients., Competing Interests: Competing interests: DA has received research funding to support a clinical research fellow from Abbott Vascular Inc. He has also received funding from AstraZeneca Inc. for unrelated research and has undertaken consultancy to support research funds for General Electric Inc. TJ has received consultancy/speaker fees from Abbott Vascular, Boston Scientific, Medtronic and Terumo. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
11. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry.
- Author
-
De Luca G, Cercek M, Jensen LO, Vavlukis M, Calmac L, Johnson T, Roura I Ferrer G, Ganyukov V, Wojakowski W, von Birgelen C, Versaci F, Ten Berg J, Laine M, Dirksen M, Casella G, Kala P, Díez Gil JL, Becerra V, De Simone C, Carrill X, Scoccia A, Lux A, Kovarnik T, Davlouros P, Gabrielli G, Flores Rios X, Bakraceski N, Levesque S, Guiducci V, Kidawa M, Marinucci L, Zilio F, Galasso G, Fabris E, Menichelli M, Manzo S, Caiazzo G, Moreu J, Sanchis Forés J, Donazzan L, Vignali L, Teles R, Bosa Ojeda F, Lehtola H, Camacho-Freiere S, Kraaijeveld A, Antti Y, Boccalatte M, Martínez-Luengas IL, Scheller B, Alexopoulos D, Uccello G, Faurie B, Gutierrez Barrios A, Wilbert B, Cortese G, Moreno R, Parodi G, Kedhi E, and Verdoia M
- Subjects
- Aged, COVID-19 diagnosis, COVID-19 mortality, Diabetes Mellitus diagnosis, Diabetes Mellitus mortality, Europe epidemiology, Female, Hospital Mortality trends, Humans, Hypertension epidemiology, Male, Middle Aged, Percutaneous Coronary Intervention adverse effects, Percutaneous Coronary Intervention mortality, Registries, Retrospective Studies, Risk Factors, ST Elevation Myocardial Infarction mortality, Time Factors, Treatment Outcome, COVID-19 epidemiology, Diabetes Mellitus epidemiology, Percutaneous Coronary Intervention trends, ST Elevation Myocardial Infarction therapy, Time-to-Treatment trends
- Abstract
Background: It has been suggested the COVID pandemic may have indirectly affected the treatment and outcome of STEMI patients, by avoidance or significant delays in contacting the emergency system. No data have been reported on the impact of diabetes on treatment and outcome of STEMI patients, that was therefore the aim of the current subanalysis conducted in patients included in the International Study on Acute Coronary Syndromes-ST Elevation Myocardial Infarction (ISACS-STEMI) COVID-19., Methods: The ISACS-STEMI COVID-19 is a retrospective registry performed in European centers with an annual volume of > 120 primary percutaneous coronary intervention (PCI) and assessed STEMI patients, treated with primary PCI during the same periods of the years 2019 versus 2020 (March and April). Main outcomes are the incidences of primary PCI, delayed treatment, and in-hospital mortality., Results: A total of 6609 patients underwent primary PCI in 77 centers, located in 18 countries. Diabetes was observed in a total of 1356 patients (20.5%), with similar proportion between 2019 and 2020. During the pandemic, there was a significant reduction in primary PCI as compared to 2019, similar in both patients with (Incidence rate ratio (IRR) 0.79 (95% CI: 0.73-0.85, p < 0.0001) and without diabetes (IRR 0.81 (95% CI: 0.78-0.85, p < 0.0001) (p int = 0.40). We observed a significant heterogeneity among centers in the population with and without diabetes (p < 0.001, respectively). The heterogeneity among centers was not related to the incidence of death due to COVID-19 in both groups of patients. Interaction was observed for Hypertension (p = 0.024) only in absence of diabetes. Furthermore, the pandemic was independently associated with a significant increase in door-to-balloon and total ischemia times only among patients without diabetes, which may have contributed to the higher mortality, during the pandemic, observed in this group of patients., Conclusions: The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a similar reduction in primary PCI procedures in both patients with and without diabetes. Hypertension had a significant impact on PCI reduction only among patients without diabetes. We observed a significant increase in ischemia time and door-to-balloon time mainly in absence of diabetes, that contributed to explain the increased mortality observed in this group of patients during the pandemic., Trial Registration Number: NCT04412655.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.